Wählen Sie Ihr Land oder Ihre Region

Sie sind jetzt bei Austria (Deutsch)
Home / Über uns / Investors / Newsroom / Arjo announces date of 2019 Q2 report and conference call
The share Arjo B 28 Nov 2023 14:07 3,18 EUR (+0,89%)
❮ Neuigkeiten

Arjo announces date of 2019 Q2 report and conference call

Arjo will issue its Q2 report for 2019 on Thursday July 18 at 07:30 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Jonas Lindqvist, CFO. The previously communicated date of July 19 has been altered for practical reasons.

We invite fund managers, analysts and the media to participate in the conference call. Please see details below to join the conference.

Swedish dial-in number: +46 (0)8 5033 6574
UK: +44 (0)330 336 9105
USA: +1 323-794-2093
Participant passcode: 9808789

During the telephone conference, a presentation will be held. To access the presentation, please use this link: https://slideassist.webcasts.com/starthere.jsp?ei=1245570

Alternatively, use the following link to download the presentation: https://www.arjo.com/int/about-us/investors/reports--presentations/2019/


07:45             Call in to the conference
08:00             Review of the Q2 report
08.30             Q&A
09.00             End of conference

A recorded version of the conference is accessible for 90 days via the following link: https://slideassist.webcasts.com/starthere.jsp?ei=1245570

For more information, please contact:                                                                                              

Kornelia Rasmussen, EVP Marketing Communications & Public Relations
Tel: +46(0)10 335 4810
E-mail: kornelia.rasmussen@arjo.com

Saloni Deva, Investor Relations & Corporate Communications
Tel: +46 (0)10 335 4867
Email: saloni.deva@arjo.com

About Arjo

At Arjo, we are committed to improving the everyday lives of people affected by reduced mobility and age-related health challenges. With products and solutions that ensure ergonomic patient handling, personal hygiene, disinfection, diagnostics, and the effective prevention of pressure ulcers and venous thromboembolism, we help professionals across care environments to continually raise the standard of safe and dignified care. Arjo has approximately 6,000 employees worldwide and customers in over 100 countries. In 2018, Arjo sales amounted to SEK 8.2 billion. Arjo is listed on Nasdaq Stockholm and its head office is located in Malmö, Sweden. Everything we do, we do with people in mind. www.arjo.com

Arjo announces date of 2019 Q2 report and conference call